Doctors study when to pull back powerful Fungus-Fighting drugs

NCT ID NCT03774316

Summary

This study observed how often doctors reduced or stopped antifungal medications in critically ill patients with weakened immune systems who were suspected of having a serious yeast infection. Researchers tracked 275 patients across 14 intensive care units to see if this 'de-escalation' was safe and what factors made it more likely. The goal was to gather information to help doctors use these strong drugs more carefully, balancing treatment needs against side effects and cost.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHU Lille

    Lille, 59000, France

Conditions

Explore the condition pages connected to this study.